Nuclear Medicine in the Diabetic Foot

Similar documents
PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

First Clinical Experience with

Nuclear Medicine and PET. D. J. McMahon rev cewood

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium

Department of Nuclear Medicine with Positron Emission Tomography

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

04/03/2013. Second Annual BIR SPECT/CT Symposium London, UK 25/02/2013. NMD: Al-Jahra Hospital. NMD: Al-Jahra Hospital

Physical Bases : Which Isotopes?

Imaging of white blood cells with Scintimun

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

A Snapshot on Nuclear Cardiac Imaging

General Nuclear Medicine

Quantitative Theranostics in Nuclear Medicine

Using PET/CT in Prostate Cancer

Positron Emission Tomography in Lung Cancer

CEREBRAL BLOOD FLOW AND METABOLISM

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

NUCLEAR MEDICINE Molecular Imaging + Endo-Radiotherapy

Physics of MBI (~10 slides)

Positron Emission Tomography Computed Tomography (PET/CT)

F NaF PET/CT in the Evaluation of Skeletal Malignancy

University of Groningen. Nuclear medicine imaging of posttraumatic osteomyelitis Govaert, G. A. M.; Glaudemans, Andor W.J.M.

Joint Comments on Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R1)

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

Radionuclides in Medical Imaging. Danielle Wilson

METROLOGY TO SUPPORT INNOVATION IN MOLECULAR RADIOTHERAPY. Glenn Flux

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

45 Hr PET Registry Review Course

SCINTIGRAPHY OF THE CENTRAL NERVOUS SYSTEM Part 1: Introduction and BBB studies

Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)

Radionuclide & Radiopharmaceuticals

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

Nuclear Medicine related studies for Prostate cancer

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

PET/MR:Techniques, Indications and Applications

Description of the consecutive stages (which took place from December 2002 to July 2003)

Multiple Gated Acquisition (MUGA) Scanning

Cardiac Nuclear Medicine

Molecular Imaging of Bone Metastasis Hojjat Ahmadzadehfar

Cardiac Imaging Tests

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

Nuclear pulmonology. Katalin Zámbó Department of Nuclear Medicine

GUNDERSEN HEATLH SYSTEM NUCLEAR MEDICINE DEPARTMENT PROTOCOL MANUAL

Austin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered])

Leucocytscintigraphy. Lene Rørdam Senior Consultant DMSci Department of Clinical Physiology and Nuclear Medicine Bispebjerg University Hospital

Basics of nuclear medicine

weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

MRI-PET: Oncologic Applications

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ

Indications of PET/CT in oncology

Molecular Imaging and the Brain

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

Option D: Medicinal Chemistry

Gastrointestinal tract

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE

Palliative treatment of bone metastases with samarium-153

Ga68 Imaging. Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

PET imaging of cancer metabolism is commonly performed with F18

CLINICAL IMPLEMENTATION OF HYBRID IMAGING CLINICAL IMPLEMENTATION OF HYBRID IMAGING COMBINED IMAGING CLINICAL IMPLEMENTATION OF

Children's (Pediatric) Nuclear Medicine

KEYWORDS: nuclear medicine; gamma camera; radiopharmaceutical activities.

Preview of Presentation

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Therapy with radionuclides

Dr Alfred O Ankrah FCNP

Bone Metastasis. Patient Management with PET/CT

Nuclear Medicine: Basics to therapy

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:

POSITRON EMISSION TOMOGRAPHY (PET)

Calculation methods in Hermes Medical Solutions dosimetry software

Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.

NUCLEAR CARDIOLOGY UPDATE

Positron Emission Tomography - Computed Tomography (PET/CT)

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Molecular Imaging and Breast Cancer

Nuclear Medicine in Thyroid Cancer. Phillip J. Koo, MD Division Chief of Diagnostic Imaging

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

ISPUB.COM. Planar fusion: A PICTORIAL REVIEW. G Currie, R Pearce, J Wheat CASE EXAMPLES INTRODUCTION

Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı

INDICATIONS AND USAGE

Radiation Exposure to Staff Using PET/CT Facility

Theranostics in Nuclear Medicine

Medical Imaging. Alex Elliott Western Infirmary Glasgow

Prostate Cancer and PSMA:

CT Optimisation for Paediatric SPECT/CT Examinations. Sarah Bell

György HEVESY ( ) 1943 Nobel Laureate in Chemistry for his work on the use of isotopes as tracers in the study of chemical processes

Molecular Imaging and Cancer

The Physics of Medical Imaging

New imaging techniques: let there be light. Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

Chapter 1. Introduction

Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT

Transcription:

26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH

Outline A. Imaging modalities brief technical overview B. Nuclear medicine in the diabetic foot C. Cases Nuclear Medicine in Diabetic Foot / 27. November 2015 1

A. Imaging modalities Nuclear Medicine in Diabetic Foot / 27. November 2015 2

A. Imaging modalities Modalities SPECT/CT PET/CT Tracers DPD (bone turnover) MoAB (infection) FDG (infection, inflammation, tumor ) Principle Adsorption to bone Granulocyte antibody Glucose analogon Nuclear Medicine in Diabetic Foot / 27. November 2015 3

The Spectrum of Radiological Imaging Method Spatial resolution Sensitivity Ultrasound 50 µm 10-3 mol CT 50 µm 10-3 mol MR 100 µm 10-5 mol PET + SPECT >1mm 10-9 - 10-12 mol Molecular Imaging M.Rudin, R.Weissleder. Molecular imaging in drug discovery and development. Nature Reviews, 2003 Feb;2(2):123-31. Nuclear Medicine in Diabetic Foot / 27. November 2015 4

The Principle of Radiological Imaging Method Principle Dose CT f (density) 1-15 msv MR f (concentration H+) - PET + SPECT f (organ function) 5-8 msv Functional Imaging Nuclear Medicine in Diabetic Foot / 27. November 2015 5

The Principle of Radiological Imaging CT Transmission scan PET, SPECT Emission scan X-ray unit X-ray detector γ-ray detector γ-ray detector Nuclear Medicine in Diabetic Foot / 27. November 2015 6

Technology Planar scintigraphy Electronics Photomultiplier Detector Collimator Patient Nuclear Medicine in Diabetic Foot / 27. November 2015 7

Technology Planar scintigraphy Bone scan Nuclear Medicine in Diabetic Foot / 27. November 2015 8

Technology SPECT (Single photon emission computed tomography) Projection in different angles Back projection Nuclear Medicine in Diabetic Foot / 27. November 2015 9

Technology SPECT/CT SPECT CT SPECT/CT SPECT/CT (3D VR) Nuclear Medicine in Diabetic Foot / 27. November 2015 10

Technology SPECT/CT Examination protocol / patient schedule Injection of radiotracer Uptake time (0 24h) Imaging (planar images, SPECT, SPECT/CT) Total radiation dose: 5 12 msv Nuclear Medicine in Diabetic Foot / 27. November 2015 11

Technology PET (Positron emission tomography) Positron emitter Event Coincidence of events: Time window 2-3 ns Event Nuclear Medicine in Diabetic Foot / 27. November 2015 12

Technology PET/CT PET 7x 2 min «low dose» CT 10 sec PET/CT Nuclear Medicine in Diabetic Foot / 27. November 2015 13

Technology PET/CT Examination protocol / patient schedule NPO 4h prior to exam (only 18 F-FDG) Blood glucose test (only 18 F-FDG) Injection of radiotracer (~340 MBq 18 F-FDG, 200 MBq 18 F-Fluoride) Uptake time (0 1h), in dark and quiet ambience Voiding Imaging (PET/CT) Total radiation dose: 8 12 msv Nuclear Medicine in Diabetic Foot / 27. November 2015 14

Technology Advantages of hybrid imaging Combination of morphological and functional data Higher spatial accuracy Higher diagnostic accuracy Nuclear Medicine in Diabetic Foot / 27. November 2015 15

Technology Advantages of hybrid imaging Combination of morphological and functional data Higher spatial accuracy Higher diagnostic accuracy Bone scan Tc-DPD SPECT 67yo male, prostate cancer with bone metastases 18 F-Fluoride PET Nuclear Medicine in Diabetic Foot / 27. November 2015 16

The Tracers Make a Difference! Tc-DPD 15 O-H 2 O Tc-MAG3 123 I 11 C-Raclopride Tc-MAA 123 I-Ioflupanum 90 Y 18 F-FET 18 F-Fluorid 68 Ga-DOTATATE 18 F-FDG 18 F-DOPA 224 Ra-Alpharadin Tc-Bridatec 186 Re 169 Er 18 F-Cholin Tc-Pertechnetat Tc-Myoview 11 C-ABP 131 I Tc-Technegas 131 I-MIBG 90 Y-Zevalin Tc-MoAB 90 Y-Therasphere Tc-DMSA Tc-RBC Tc-DTPA 11 C-PiB 13 N-NH Tc-Nanocoll 3 123 I-MIBG 177 Lu-DOTATATE 15 O 2 More than 200 different radiotracers available in clinical and experimental setups. Nuclear Medicine in Diabetic Foot / 27. November 2015 17

The Tracers Make a Difference! Tc-DPD 15 O-H 2 O Tc-MAG3 123 I 11 C-Raclopride Tc-MAA 123 I-Ioflupanum 90 Y 18 F-FET 18 F-Fluorid 68 Ga-DOTATATE 18 F-FDG 18 F-DOPA 224 Ra-Alpharadin Tc-Bridatec 186 Re 169 Er 18 F-Cholin Tc-Pertechnetat Tc-Myoview 11 C-ABP 131 I Tc-Technegas 131 I-MIBG 90 Y-Zevalin Tc-MoAB 90 Y-Therasphere Tc-DMSA Tc-RBC Tc-DTPA 11 C-PiB 13 N-NH Tc-Nanocoll 3 123 I-MIBG 177 Lu-DOTATATE 15 O 2 Relevant diagnostic radiotracers in diabetic foot imaging Nuclear Medicine in Diabetic Foot / 27. November 2015 18

The Tracers Make a Difference! Radionuclide (+ Carrier) = Radiopharmaceutical («Radiotracer») Technetium-DPD Tc 56 99 Tc 56 + γ ( t / 2 : 6h) Nuclear Medicine in Diabetic Foot / 27. November 2015 19

Radiotracers for Diabetic Foot Imaging Relevant diagnostic radiotracers in diabetic foot imaging Radiotracer Target Cell ED (70kg patient) Tc-DPD Hydroxyapatite crystal Osteoblasts Tc-MoAB NCA-95 antigen Granulocytes + precursors 18 F-FDG Hexokinase Glucose consuming cells 4.4 msv 6-8 msv 6-8 msv Erba PA, Israel O. SPECT/CT in infection and inflammation. Clin Translat Med, 2014 Dec;2(2):92-9. Nuclear Medicine in Diabetic Foot / 27. November 2015 20

Radiotracers for Diabetic Foot Imaging Relevant diagnostic radiotracers in diabetic foot imaging Tool Radiotracer Cell Process imaged SPECT/CT Tc-DPD Osteoblasts Bone turnover Tc-MoAB Granulocytes + precursors PET/CT 18 F-FDG Glucose consuming cells Infection Tumor, infection, inflammation non-specific specific non-specific Erba PA, Israel O. SPECT/CT in infection and inflammation. Clin Translat Med, 2014 Dec;2(2):92-9. Nuclear Medicine in Diabetic Foot / 27. November 2015 21

Radiotracers for Diabetic Foot Imaging Normal Distribution 18 F-FDG Tc-DPD Tc-MoAB Glucose consumption (and excretion) Bone turnover (and excretion) Granulocytes (and precursors) Nuclear Medicine in Diabetic Foot / 27. November 2015 22

The Tracers Make a Difference! Lateral wedge: Normal uptake after HTO Medial wedge: Infection of osteotomy gap Same patient, exams are two days apart Tc-DPD SPECT/CT Tc-MoAB SPECT/CT Conclusion? Nuclear Medicine in Diabetic Foot / 27. November 2015 23

Radiotracers for Diabetic Foot Imaging Question: FDG-PET/CT: How much radioactive sugar (FDG) do patients get per scan? A) 1 g B) 1 mg C) 1 µg D) 1 ng Nuclear Medicine in Diabetic Foot / 27. November 2015 24

Radiotracers for Diabetic Foot Imaging Question: FDG-PET/CT: How much radioactive sugar (FDG) do patients get per scan? A) 1 g B) 1 mg C) 1 µg D) 1 ng Nuclear Medicine in Diabetic Foot / 27. November 2015 25

Radiotracers for Diabetic Foot Imaging Can I scan patients with? Allergy to contrast medium? Renal insufficiency? Pacemaker? Hyperthyroidism? Claustrophobia? Nuclear Medicine in Diabetic Foot / 27. November 2015 27

Radiotracers for Diabetic Foot Imaging CT MR PET/MR PET/CT SPECT/CT Nuclear Medicine in Diabetic Foot / 27. November 2015 28

B. Nuclear Medicine in the Diabetic Foot Nuclear Medicine in Diabetic Foot / 27. November 2015 29

B. Nuclear Medicine in the Diabetic Foot Diabetic Foot Ulceration Major complication of diabetes mellitus - Incidence: 2% per year - Major cause of hospitalization of diabetic patients - Consequences: Loss of quality of life, healthcare costs - High mortality: Life expectancy reduced by 14 years (!) in a diabetic patient with neuropathic ulcer without infection or ischemia (compared to non-diabetic patient) Lipsky BA et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):1679-84. Nuclear Medicine in Diabetic Foot / 27. November 2015 30

B. Nuclear Medicine in the Diabetic Foot Diabetic Foot Ulceration with Infection - >50% of diabetic ulcers are infected at presentation - Most important reason for amputation - Independent risk factor for death Early diagnosis of infection is key! Lipsky BA et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):1679-84. Prompers L et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007 Jan;50(1):18-25. Nuclear Medicine in Diabetic Foot / 27. November 2015 31

Diabetic Foot: Diagnosing an Infection Problem: Differentiation of osteomyelitis, soft tissue infection, inflammation and osteoarthropathy is difficult. 1. All open wounds: Colonized with microorganisms. 2. Neuropathy and vascular disease: May diminish or mimic inflammation. Clinical problem Clinical + imaging problem Lipsky BA et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):1679-84. Prompers L et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007 Jan;50(1):18-25. Nuclear Medicine in Diabetic Foot / 27. November 2015 32

Diabetic Foot: Imaging of Infections X-ray, MRI, Bone scan (DPD), Leucocyte scan (MoAB), or PET/CT (FDG)? - No evidence of one single superior imaging modality - Only few small studies so far - Several societies are currently collaborating on guidelines (EANM, EBJIS, EASD) X-ray MRI DPD- SPECT/CT MoAB- SPECT/CT FDG- PET/CT Sensitivity 60% 90% 90% 72-100% 29-100% Specificity 80% 80% 50% 67-100% 67-93% Cost (CHF) 120 600 1400 2500 2100 Glaudemans AW et al. Challenges in diagnosing infection in the diabetic foot. Diabet Med. 2015 Jun;32(6):748-59. Nuclear Medicine in Diabetic Foot / 27. November 2015 33

Diabetic Foot: Imaging of Infections Modality Advantages Disadvantages DPD-SPECT/CT Availability Long experience MoAB-SPECT/CT Specific for granulocytes Not affected by antibiotics Detects acute + chronic infection FDG-PET/CT Long experience Short acquisition time (2h) Low specificity: Uptake in any lesion with increased bone turnover Sterile laboratory required Long acquisition time (patient returns after 24h) Often unspecific: Uptake in infection, inflammation, osteoarthropathy, tumor Glaudemans AW et al. Challenges in diagnosing infection in the diabetic foot. Diabet Med. 2015 Jun;32(6):748-59. Nuclear Medicine in Diabetic Foot / 27. November 2015 34

Diabetic Foot: Imaging of Infections The Course of Disease And when to Image with Nuclear Medicine Diabetic foot Neuropathic ulcer Soft tissue infection Neuropathic joint (Charcot) Bone infection (Osteomyelitis) Differentiation sometimes difficult Nuclear Medicine Imaging Nuclear Medicine in Diabetic Foot / 27. November 2015 35

Diabetic Foot: Imaging of Infections Which modality is most helpful? DPD-SPECT/CT MoAB-SPECT/CT FDG-PET/CT Nuclear Medicine in Diabetic Foot / 27. November 2015 36

Diabetic Foot: Imaging of Infections Which modality is most helpful? DPD-SPECT/CT MoAB-SPECT/CT FDG-PET/CT Nuclear Medicine in Diabetic Foot / 27. November 2015 37

C. Cases Nuclear Medicine in Diabetic Foot / 27. November 2015 39

Diabetic Foot Radiotracer: 18 F-FDG Radiotracer: Tc-MoAB T1w Gado PET/CT PET SPECT 70 yo male, infected wound Dig. IV. Question: Osteomyelitis? Answer: Yes. Nuclear Medicine in Diabetic Foot / 27. November 2015 40

Diabetic Foot T1w Gado X-ray STIR 73 yo male, skin necrosis of toes. Question: Osteomyelitis? (Or: Which toes will be amputated?) Osteomyelitis? Nuclear Medicine in Diabetic Foot / 27. November 2015 43

Diabetic Foot Radiotracer: Tc-MoAB STIR Tc-MoAB SPECT/CT 73 yo male, skin necrosis of toes. Question: Osteomyelitis? (Or: Which toes will be amputated?) Answer: Yes: Dig. I + III. Nuclear Medicine in Diabetic Foot / 27. November 2015 44

Osteomyelitis Radiotracer: Tc-MoAB Nuclear Medicine in Diabetic Foot / 27. November 2015 45

Diabetic Foot Radiotracer: Tc-MoAB Osteomyelitis? Bone infarction? Answer: Osteomyelitis + Soft tissue infection T1w Gd STIR SPECT/CT 70 yo male, clinical infection of amputation stump. Question: Osteomyelitis? Nuclear Medicine in Diabetic Foot / 27. November 2015 46

Diabetic Foot Small ulcus with minimal infection Fistula Radiotracer: Tc-MoAB Soft tissue infection No osteomyelitis MoAB (5h) MoAB (24h) 75 yo female, h/o forefoot amputation. Now: Skin ulcers. Question: Infection? Osteomyelitis? MoAB-SPECT/CT Nuclear Medicine in Diabetic Foot / 27. November 2015 47

Soft tissue infection + fistula Radiotracer: Tc-MoAB Nuclear Medicine in Diabetic Foot / 27. November 2015 48

Conclusion The Value of Nuclear Medicine in the Diabetic Foot First line: MRI, X-ray Second line: Nuclear medicine If questions remain after MRI If patient cannot undergo MRI Nuclear Medicine in Diabetic Foot / 27. November 2015 53

Questions? Nuclear Medicine in Diabetic Foot / 27. November 2015 55